Paclitaxel is known as the most effective anti-cancer drug against OC, but its effectiveness reduced by the emergence of MDR phenotype often arise due to the overexpression of MRP1 in this cancer [34,35,36]. This evidence concerns the gene ABCC1 and cancer.